STEPHEN DALE
CIK 1821709 · Chief Medical Officer · last filed 2024-01-31
STEPHEN DALE is a Chief Medical Officer who has filed 8 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing shows the insider sold $231.4K of KURA on Jan 31, 2024. Across all open-market trades the lifetime net is −$359.4K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $484.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$484.9K
1
8
-$359.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KURA | Chief Medical Officer | 46,400 | $10.45 | $484.9K | -$359.4K | 7 | 2024-01-31 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-01-31 | KURA | Sell (S) | −11,983 | -$231.4K | EDGAR |
| 2024-01-30 | KURA | Notice (144) | −4,825 | -$89.3K | EDGAR |
| 2024-01-04 | KURA | Grant (A) | — | $0 | EDGAR |
| 2023-02-21 | KURA | Grant (A) | +23,125 | $0 | EDGAR |
| 2023-01-31 | KURA | Sell (S) | −9,225 | -$128.0K | EDGAR |
| 2022-01-28 | KURA | Grant (A) | +36,900 | $0 | EDGAR |
| 2021-01-28 | KURA | Grant (A) | — | $0 | EDGAR |
| 2020-08-25 | KURA | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.